Stanford Memory and Aging Study
Language
Undefined
Purpose: To study memory and aging in healthy older adults. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - July 2, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials
Nutritional Supplement and Brain Imaging Study
Language
Undefined
Purpose: To evaluate the effects of a proprietary nutritional supplement on cognition, mood, and brain imaging results. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - June 29, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials
Insulin Aspart to Fight Forgetfulness
Language
Undefined
Purpose: To test the effects of fast-acting intranasal insulin on cognition and daily function in people with Alzheimer's disease or mild cognitive impairment. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - June 29, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials
Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)
Language
Undefined
Purpose: To build a clinical research consortium to test new treatments for people with frontotemporal lobar degeneration. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - June 29, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials
Memory & Exercise Training in Older Adults with Subjective Memory Complaints
Language
Undefined
Purpose: To assess the cognitive impact of a program of memory training and aerobic exercise in people with subjective memory complaints. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - May 18, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials
Azeliragon (TTP488) for Mild Alzheimer's Disease (STEADFAST)
Language
Undefined
Purpose: To evaluate the efficacy and safety of the experimental drug azeliragon in people with mild Alzheimer's disease. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - May 18, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials
Home Exercise for Seniors with Dementia and Their Caregivers
Language
Undefined
Purpose: To determine the feasibility of an exercise program for older adults with dementia living at home and their caregivers. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - May 18, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials
Longitudinal Evaluation of Familial Frontotemporal Dementia (LEFFTDS)
Language
Undefined
Purpose: To learn about thinking and behavior in families in which one or more relatives has a genetic mutation associated with frontotemporal dementia. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - May 18, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials
Characterizing Cognitive Decline in Late-Life Depression (ADNI-D)
Language
Undefined
Purpose: To characterize the biological mechanisms contributing to cognitive impairment and decline in older adults with depression. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - May 7, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials
MIND-S: Care Coordination for Community-living People with Dementia
Language
Undefined
Purpose: To evaluate a home-based dementia care intervention for people with dementia and their family caregivers. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - April 22, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials
Home-based Dementia Care Coordination for Medicare-Medicaid Recipients
Language
Undefined
Purpose: To implement and evaluate a home-based dementia care coordination program called MIND at Home-Plus. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - April 22, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials
GC021109 for Mild to Moderate Alzheimer's Disease
Language
Undefined
Purpose: To test the safety and pharmacokinetics of the experimental drug GC021109 in people with mild to moderate Alzheimer's disease. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - April 22, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials
